| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
NAMS
NewAmsterdam Pharma Company
|
Aug 07, 2025 | BUY |
Strong Buy
+54.8% avg upside
18 analysts
|
$52.00
75.05% Upside
|
+29.9% |
|
BMEA
Biomea Fusion
|
Aug 06, 2025 | BUY |
Strong Buy
+1020.0% avg upside
15 analysts
|
$10.00
740.38% Upside
|
-8.2% |
|
URGN
Urogen Pharma
|
Aug 06, 2025 | BUY |
Strong Buy
+15.4% avg upside
16 analysts
|
$47.00
44.08% Upside
|
+52.2% |
|
SNDX
Syndax Pharmaceuticals
|
Aug 05, 2025 | HOLD |
Strong Buy
+87.3% avg upside
27 analysts
|
$17.00
11.32% Downside
|
+45.7% |
|
BMRN
BioMarin Pharmaceutical
|
Aug 05, 2025 | HOLD |
Strong Buy
+71.7% avg upside
52 analysts
|
$80.00
45.68% Upside
|
-11.2% |
|
BIIB
Biogen
|
Aug 01, 2025 | BUY |
Strong Buy
+24.4% avg upside
51 analysts
|
$224.00
15.32% Upside
|
+50.6% |
|
ARGX
Argenx Se
|
Aug 01, 2025 | BUY |
Strong Buy
-16.4% avg upside
46 analysts
|
$796.00
8.44% Downside
|
+31.0% |
|
INMB
Inmune Bio
|
Jul 30, 2025 | SELL |
Buy
+834.0% avg upside
11 analysts
|
$0.60
54.97% Downside
|
+53.7% |
|
JANX
Janux Therapeutics Inc
|
Jul 25, 2025 | HOLD |
Strong Buy
+220.6% avg upside
21 analysts
|
$36.00
158.14% Upside
|
-45.5% |
|
LEGN
Legend Biotech
|
Jul 17, 2025 | BUY |
Strong Buy
+115.9% avg upside
27 analysts
|
$76.00
161.08% Upside
|
-14.9% |
|
VKTX
Viking Therapeutics
|
Jun 26, 2025 | BUY |
Strong Buy
+141.0% avg upside
30 analysts
|
$102.00
236.03% Upside
|
+5.2% |
|
KURA
Kura Oncology
|
Jun 04, 2025 | HOLD |
Strong Buy
+170.6% avg upside
26 analysts
|
$8.00
16.44% Downside
|
+36.0% |
|
AURA
Aura Biosciences Inc
|
May 16, 2025 | BUY |
Strong Buy
+238.0% avg upside
9 analysts
|
$23.00
268.79% Upside
|
+30.1% |
|
TPST
Tempest Therapeutics
|
May 14, 2025 | HOLD |
Buy
+1646.8% avg upside
18 analysts
|
$9.00
619.92% Upside
|
-68.1% |
|
ADAPY
Adaptimmune Therapeutics
|
May 14, 2025 | BUY |
Buy
+5717.9% avg upside
10 analysts
|
$1.40
3399.97% Upside
|
· |
|
ABSI
AbSci
|
May 14, 2025 | BUY |
Strong Buy
+40.1% avg upside
18 analysts
|
$13.00
79.49% Upside
|
+90.4% |
|
CGON
CG Oncology, Inc.
|
May 14, 2025 | HOLD |
Strong Buy
+42.0% avg upside
17 analysts
|
$23.00
62.07% Downside
|
+187.7% |
|
TARA
Protara Therapeutics
|
May 09, 2025 | BUY |
Strong Buy
+1134.8% avg upside
21 analysts
|
$12.00
195.53% Upside
|
+62.6% |
|
SKYE
Skye Bioscience
|
May 09, 2025 | BUY |
Strong Buy
+1327.3% avg upside
9 analysts
|
$20.00
2610.41% Upside
|
-52.5% |
|
ARVN
Arvinas Holding Company
|
Dec 14, 2020 | BUY |
Buy
+266.4% avg upside
27 analysts
|
$114.00
1405.86% Upside
|
-22.5% |
|
CCCC
C4 Therapeutics
|
Dec 08, 2020 | BUY |
Strong Buy
+354.5% avg upside
19 analysts
|
$45.00
1053.89% Upside
|
+12.7% |
|
PTGX
Protagonist Therapeutics
|
Dec 07, 2020 | BUY |
Strong Buy
-21.5% avg upside
19 analysts
|
$46.00
58.86% Downside
|
+47.6% |
|
MRNA
Moderna
|
Nov 17, 2020 | HOLD |
Hold
+9.4% avg upside
38 analysts
|
$109.00
73.48% Upside
|
+160.0% |
|
INCY
Incyte
|
Nov 06, 2020 | HOLD |
Buy
+1.0% avg upside
47 analysts
|
$87.00
9.60% Downside
|
-18.4% |
|
EXEL
Exelixis
|
Sep 21, 2020 | HOLD |
Strong Buy
-21.4% avg upside
33 analysts
|
$27.00
47.24% Downside
|
-21.2% |
|
BBIO
BridgeBio Pharma
|
Aug 12, 2020 | BUY |
Strong Buy
+36.6% avg upside
34 analysts
|
$44.00
33.12% Downside
|
+76.0% |
|
IMUX
Immunic
|
Aug 03, 2020 | BUY |
Strong Buy
+166.9% avg upside
21 analysts
|
$61.00
332.25% Upside
|
-58.9% |
|
AGIO
Agios Pharma
|
Dec 09, 2019 | BUY |
Strong Buy
+78.4% avg upside
29 analysts
|
$49.00
45.94% Upside
|
-19.5% |
|
NKTR
Nektar Therapeutics
|
Nov 11, 2019 | BUY |
Buy
+18.4% avg upside
25 analysts
|
$46.00
23.35% Downside
|
-18.4% |
|
EDIT
Editas Medicine
|
May 08, 2019 | BUY |
Buy
+434.5% avg upside
33 analysts
|
$40.00
1438.47% Upside
|
-1.7% |
|
MDGL
Madrigal Pharmaceuticals
|
Feb 23, 2012 | BUY |
Strong Buy
-4.7% avg upside
31 analysts
|
$8.00
98.36% Downside
|
+65.6% |
|
VRTX
Vertex Pharmaceuticals
|
Feb 03, 2012 | HOLD |
Strong Buy
-3.9% avg upside
61 analysts
|
$34.00
92.50% Downside
|
+23.5% |
|
TCRT
Alaunos Therapeutics
|
Nov 10, 2011 | BUY |
Buy
+582.8% avg upside
13 analysts
|
$9.00
310.04% Upside
|
+7.1% |
|
OSIS
OSI Systems
|
Mar 02, 2010 | HOLD |
Strong Buy
+0.6% avg upside
11 analysts
|
— | +24.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.